Catholic Health Initiatives' launches corporate reorganization, and other news

Modern Healthcare

  • Top executives at Catholic Health Initiatives, one of the largest U.S. health systems, will take on new roles under a corporate reorganization. Kevin Lofton, 59, will remain CEO of the Englewood, Colo.-based system, a role he has held since 2003, but will step down as its president. Lofton will oversee the system's strategic direction and potential deals. Two executives will succeed Lofton as president, a move that will position the hospital system “effectively for the dramatic and rapid changes we are experiencing in the healthcare industry,” Lofton said. Michael Rowan, 56, executive vice president and chief operating officer, was named president of health system delivery. Dean Swindle, 53, executive vice president for business services and chief financial officer, was named president of enterprise business lines. Rowan will keep his role as COO and Swindle will continue as CFO.

  • New Hampshire state Senate leaders announced a bipartisan deal Feb. 6 to expand Medicaid to about 49,000 poor New Hampshire adults by using federal funds to pay for private insurance. The agreement was the culmination of private negotiations since efforts to expand Medicaid failed during a special session in November. The framework would expand access to private health insurance by using an existing state program that subsidizes employer-based insurance and by buying private coverage through the federal marketplace.

  • The Obama administration may be considering an extension of the president's decision to let people keep their individual insurance policies even if they are not compliant with the Patient Protection and Affordable Care Act. Avalere Health CEO Dan Mendelson said he has had informal discussions with administration officials suggesting they may let policyholders keep that coverage for another three years, according to the Associated Press. Aetna CEO Mark Bertolini mentioned the possibility during a call with investors last week. “All of that's on the table and we're working through that,” he said.
    • Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Covid-vaccination-Bloomberg-0824
    FDA approves updated Pfizer, Moderna Covid shots as cases rise
    Most Popular
    1
    UnitedHealthcare sues over Medicare Advantage ratings downgrade
    2
    What a Harris or Trump win means for the ACA, health insurance
    3
    CMS keeps raising the bar for Medicare Advantage star ratings
    4
    Why Labcorp, Quest Diagnostics are buying hospital labs
    5
    Humana plunges as Medicare star ratings drop threatens revenue